Midjourney, best known for its generative AI image generator, is making an unexpected leap into health care with an ambitious plan to build full-body scanners that it says could transform how people monitor their health.
The startup has unveiled Midjourney Medical, a new initiative centered on an experimental imaging system that aims to scan the human body in about 60 seconds using ultrasound waves and AI. The long-term goal is to make advanced health imaging as routine as a visit to a spa, according to the startup’s blog post.
The announcement marks a dramatic expansion beyond generative AI and places Midjourney in the increasingly crowded race to apply AI to medicine.
“We’ve dreamed of something as powerful as MRI, and as casual as a trip to the spa,” the startup said.
The proposed system, called the Midjourney Scanner, would immerse a person in a pool of water while a ring containing roughly 500,000 microscopic ultrasound elements sends sound waves through the body. Those waves would then be analyzed by AI systems to reconstruct detailed three-dimensional images of organs, tissues, muscles and bones.
According to Midjourney, the scanner would generate terabytes of data per second and create body maps with resolution approaching that of MRI systems while operating nearly 100 times faster.
Midjourney envisions the technology becoming a routine health-monitoring tool rather than a specialized medical procedure.
To support that vision, the company also announced plans for the first Midjourney Spa, scheduled to open in San Francisco in 2027. The facility would combine traditional wellness offerings such as hot tubs, saunas and cold plunges with regular body scans.
“The scans are a side-effect,” the company said. “You barely think of them when going to the spa. But suddenly, you have a huge library of data about your health.”
Midjourney said its ultimate ambition is to create a global network of more than 50,000 scanners by 2031, capable of performing up to one billion scans per month.
The path from concept to reality remains uncertain.
Medical imaging devices typically face years of testing and regulatory review before they can be used for diagnostic purposes. Midjourney acknowledged that regulatory approval, including clearance from the U.S. Food and Drug Administration, could become the primary bottleneck after technical development.
The startup said it plans to spend the next year refining hardware and algorithms while conducting research trials. Initial deployments would focus on body-composition mapping and non-diagnostic imaging, with additional capabilities added over time through regulatory submissions.